Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Celgene receives patent for SelCID

Aug. 21, 1997

Boston Life Sciences completes phase III trial of Therafectin

Aug. 20, 1997

Salagen approved for Sjogren's syndrome in Canada

Aug. 20, 1997

New treatment for osteoarthritis approved for marketing in U.S.

Aug. 18, 1997

Antiinflammatory drugs in early development at Searle

Aug. 13, 1997

MMP/TNF-alpha inhibitors from Novartis

Aug. 12, 1997

Amarillo Biosciences completes enrollment for phase II study on Sjogren's syndrome

Aug. 12, 1997

Cephalon reports cysteine/serine protease inhibitors with broad therapeutic potential

Aug. 11, 1997

Antiarthritic activity of British Biotech MMP/TNF-alpha inhibitors

Aug. 8, 1997

Nabumetone shows superior safety profile in comparative study

Aug. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...